Skip Nav Destination
IDCH: is it now determined?
Open Access
PETAL: a global view on R/R T-/NK-lymphoma treatment reality
Open Access
MRD-driven phase 2 study of daratumumab, carfilzomib, lenalidomide, and dexamethasone in newly diagnosed multiple myeloma
Open Access
Venetoclax plus low-intensity chemotherapy for adults with acute lymphoblastic leukemia
Open Access
Global outcomes and prognosis for relapsed/refractory mature T-cell and NK-cell lymphomas: results from the PETAL consortium
Open Access
PETAL: a global view on R/R T-/NK-lymphoma treatment reality
Open Access
Evolving racial/ethnic disparities in AML survival in the novel therapy era
Open Access
Measurable residual disease as predictor of post–day +100 relapses after allografting in adult AML
Open Access
Recurrent ETV3::NCOA2 fusions and MAPK pathway mutations in indeterminate dendritic cell histiocytosis
Open Access
IDCH: is it now determined?
Open Access
Issue Archive
February 11 2025
Table of Contents
INSIDE BLOOD ADVANCES
IDCH: is it now determined?
Open Access
Clinical Trials & Observations
PETAL: a global view on R/R T-/NK-lymphoma treatment reality
Open Access
Clinical Trials & Observations
CLINICAL TRIALS AND OBSERVATIONS
MRD-driven phase 2 study of daratumumab, carfilzomib, lenalidomide, and dexamethasone in newly diagnosed multiple myeloma
Open Access
Clinical Trials & Observations
Manisha Bhutani,Myra Robinson,David Foureau,Shebli Atrash,Barry Paul,Fei Guo,Jason M. Grayson,Anna Ivanina-Foureau,Mauricio Pineda-Roman,Cindy Varga,Reed Friend,Christopher J. Ferreri,Xhevahire Begic,Sarah Norek,Tiffany Drennan,Michelle B. Anderson,James T. Symanowski,Peter M. Voorhees,Saad Z. Usmani
Venetoclax plus low-intensity chemotherapy for adults with acute lymphoblastic leukemia
Open Access
Clinical Trials & Observations
Marlise R. Luskin,Shai Shimony,Julia Keating,Eric S. Winer,Jacqueline S. Garcia,Richard M. Stone,Elias Jabbour,Yael Flamand,Kristen Stevenson,Jeremy Ryan,Zhihong Zeng,Anthony Letai,Marina Konopleva,Nitin Jain,Daniel J. DeAngelo
HEALTH SERVICES AND OUTCOMES
IMMUNOBIOLOGY AND IMMUNOTHERAPY
Congenital T-cell activation impairs transitional-to-follicular B-cell maturation in humans Open Access
Hugues Allard-Chamard,Kirsty Hillier,Michelle L. Ramseier,Alice Bertocchi,Naoki Kaneko,Katherine Premo,Grace Yuen,Marshall Karpel,Vinay S. Mahajan,Christina Tsekeri,Joseph S. Hong,Jean Vencic,Rory Crotty,Anish V. Sharda,Sara Barmettler,Emma Westermann-Clark,Jolan E. Walter,Musie Ghebremichael,Alex K. Shalek,Jocelyn R. Farmer,Shiv Pillai
Development and validation of predictive models of early immune effector cell–associated hematotoxicity Open Access
Emily C. Liang,Jennifer J. Huang,Andrew J. Portuguese,Valentín Ortiz-Maldonado,Aya Albittar,Natalie Wuliji,Ryan Basom,Yein Jeon,Qian Wu,Aiko Torkelson,Delaney Kirchmeier,Abigail Chutnik,Barbara Pender,Mohamed Sorror,Joshua A. Hill,Noam E. Kopmar,Rahul Banerjee,Andrew J. Cowan,Damian Green,Ajay K. Gopal,Christina Poh,Mazyar Shadman,Alexandre V. Hirayama,Brian G. Till,Erik L. Kimble,Lorenzo Iovino,Aude G. Chapuis,Folashade Otegbeye,Ryan D. Cassaday,Filippo Milano,Cameron J. Turtle,David G. Maloney,Jordan Gauthier
LYMPHOID NEOPLASIA
A real-world comparison of commercial-use axicabtagene ciloleucel and lisocabtagene maraleucel in large B-cell lymphoma Open Access
Andrew Looka,David A. Qualls,Daniel Matthews,Robert A. Redd,Christopher Sakellis,Caitlyn Duffy,Jamie Dela Cruz,Anna Saucier,Philippe Armand,Jennifer L. Crombie,David C. Fisher,Eric D. Jacobsen,Austin I. Kim,Ann S. LaCasce,Reid W. Merryman,Erin M. Parry,Caron A. Jacobson
Antileukemia efficacy of the dual BCL2/BCL-XL inhibitor AZD0466 in acute lymphoblastic leukemia preclinical models Open Access
Sankaranarayanan Kannan,Yizhen Li,Natalia Baran,Xu Yang,Sanaz Ghotbaldini,Qi Zhang Tatarata,Satoshi Yoshimura,Zhenhua Li,YuChih Hsiao,Srividya Balachander,Courtney L. Andersen,Justin Cidado,Jiyang Yu,Nitin Jain,Jun J. Yang,Marina Konopleva
Global outcomes and prognosis for relapsed/refractory mature T-cell and NK-cell lymphomas: results from the PETAL consortium
Open Access
Clinical Trials & Observations
Jessy Xinyi Han,Min Jung Koh,Leora Boussi,Mark Sorial,Sean M. McCabe,Luke Peng,Shambhavi Singh,Ijeoma Julie Eche-Ugwu,Judith Gabler,Maria J. Fernandez Turizo,Caroline T. MacVicar,Aditya Garg,Alexander Disciullo,Kusha Chopra,Alexandra Lenart,Emmanuel Nwodo,Jeffrey Barnes,Min Ji Koh,Eliana Miranda,Carlos Chiattone,Robert Stuver,Steven M. Horwitz,Mwanasha Merrill,Eric Jacobsen,Martina Manni,Monica Civallero,Tetiana Skrypets,Athina Lymboussaki,Massimo Federico,Yuri Kim,Jin Seok Kim,Jae Yong Cho,Thomas Eipe,Tanuja Shet,Epari Sridhar,Alok Shetty,Saswata Saha,Hasmukh Jain,Manju Sengar,Carrie Van Der Weyden,Henry Miles Prince,Ramzi Hamouche,Tinatin Murdashvili,Francine Foss,Marianna Gentilini,Beatrice Casadei,Pier Luigi Zinzani,Takeshi Okatani,Noriaki Yoshida,Sang Eun Yoon,Won-Seog Kim,Girisha Panchoo,Zainab Mohamed,Estelle Verburgh,Jackielyn Cuenca Alturas,Mubarak Al-Mansour,Josie Ford,Maria Elena Cabrera,Amy Ku,Govind Bhagat,Helen Ma,Ahmed Sawas,Khyati Maulik Kariya,Makoto Iwasaki,Forum Bhanushali,Owen A. O’Connor,Enrica Marchi,Changyu Shen,Devavrat Shah,Salvia Jain
PETAL: a global view on R/R T-/NK-lymphoma treatment reality
Open Access
Clinical Trials & Observations
MYELOID NEOPLASIA
RAPID-CRISPR: highly sensitive diagnostic assay for detection of PML::RARA isoforms in acute promyelocytic leukemia Open Access
Akash Maity,Amritha Sathyanarayanan,Rohit Kumar,Jesal Vora,Jitendra Gawde,Hasmukh Jain,Bhausaheb Bagal,P. G. Subramanian,Manju Sengar,Navin Khattry,Nikhil Patkar,Syed K. Hasan
Evolving racial/ethnic disparities in AML survival in the novel therapy era
Open Access
Clinical Trials & Observations
Xin Wang,Phyllis A. Gimotty,Andrew H. Matthews,Ronac Mamtani,Selina M. Luger,Elizabeth O. Hexner,Daria V. Babushok,Shannon R. McCurdy,Noelle V. Frey,Ximena Jordan Bruno,Saar Gill,Mary Ellen Martin,Vikram R. Paralkar,Ivan Maillard,David L. Porter,Alison W. Loren,Alexander E. Perl,Keith W. Pratz,Kelly D. Getz,Catherine Lai
PLASMA CELL DISORDERS
Clinical impact of [18F]FDG-PET/CT in ARI0002h treatment, a CAR-T against BCMA for relapsed/refractory multiple myeloma Open Access
Inés Zugasti,Marta Tormo-Ratera,Aina Oliver-Caldés,Juan Carlos Soler-Perromat,Verónica González-Calle,David F. Moreno,Valentín Cabañas,Nieves López-Muñoz,Álvaro Bartolomé-Solanas,Marta Español-Rego,Juan Luis Reguera-Ortega,Laura Rosiñol,Lucía López-Corral,Natalia Tovar,Luis Gerardo Rodríguez-Lobato,Rosa Maria Alvarez Perez,Sara Varea,Eulàlia Olesti,Adolfo Gomez-Grande,Laura Frutos,Pilar Tamayo,Manel Juan,José M. Moraleda,Álvaro Urbano-Ispizua,E. Azucena González-Navarro,Joaquín Martínez-López,Maria-Victoria Mateos,Xavier Tomás,Xavier Setoain,Carlos Fernández de Larrea
PLATELETS AND THROMBOPOIESIS
Clonal hematopoiesis in patients with autoimmune thrombocytopenia: an international multicenter study Open Access
Bruno Fattizzo,Alfredo Marchetti,Alessandro Bosi,Carmelo Gurnari,Juri Alessandro Giannotta,Giacinto Luca Pedone,Elena Rossi,Valentina Carrai,Andrea Guido,Filippo Brioschi,Monica Carpenedo,Monica Crugnola,Domenica Caramazza,Livia Leuzzi,Monia Marchetti,Gabriele Merati,Simona Malato,Fabrizio Vianello,Andrea Patriarca,Hussein Awada,Marta Bortolotti,Marta Canzi,Niccolò Bolli,Marco Capecchi,Frederick Chen,Andrea Artoni,Jaroslaw P. Maciejewski,Wilma Barcellini
THROMBOSIS AND HEMOSTASIS
TRANSPLANTATION
Measurable residual disease as predictor of post–day +100 relapses after allografting in adult AML
Open Access
Clinical Trials & Observations
Naveed Ali,Megan Othus,Eduardo Rodríguez-Arbolí,Corentin Orvain,Filippo Milano,Brenda M. Sandmaier,Chris Davis,Ryan S. Basom,Frederick R. Appelbaum,Roland B. Walter
PTCy-based graft-versus-host disease prophylaxis for matched sibling donor allogeneic hematopoietic cell transplantation Open Access
Nihar Desai,Majed Altareb,Mats Remberger,Carol Chen,Tommy Alfaro Moya,Eshrak Al-Shaibani,Igor Novitzky-Basso,Ivan Pasic,Wilson Lam,Fotios V. Michelis,Armin Gerbitz,Auro Viswabandya,Rajat Kumar,Dennis Dong Hwan Kim,Jeffrey H. Lipton,Jonas Mattsson,Arjun Datt Law
RESEARCH LETTERS
Recurrent ETV3::NCOA2 fusions and MAPK pathway mutations in indeterminate dendritic cell histiocytosis
Open Access
Clinical Trials & Observations
Paul G. Kemps,F. J. Sherida H. Woei-A-Jin,Koen D. Quint,Cor van den Bos,Leonie Naeije,Jan A. M. van Laar,Isabelle Vanden Bempt,Marco J. Koudijs,Ruben H. P. Vorderman,Ellen Stelloo,Joost F. Swennenhuis,Annette H. Bruggink,Konnie M. Hebeda,Marijn A. Scheijde-Vermeulen,Gilles F. H. Diercks,Robert M. Verdijk,Patty M. Jansen,Esther Hauben,Thomas Tousseyn,Arjen H. G. Cleven,Tom van Wezel,Astrid G. S. van Halteren,Pancras C. W. Hogendoorn
IDCH: is it now determined?
Open Access
Clinical Trials & Observations
RESPONSE
-
Cover Image
Cover Image
Diaminofluorescein-FM diacetate staining reveals nitric oxide accumulation after injury to a zebrafish larval tail, a phenotype absent in proc-/- (protein C) mutants. See the article by Ku et al.
Advertisement intended for health care professionals
Advertisement intended for health care professionals


















Caregiver signaling questions in sickle cell disease Open Access